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Objectives: In 2012 and 2014 the Norwegian monitoring programme for antimicrobial resistance in the
veterinary and food production sectors (NORM-VET) showed that 124 of a total of 406 samples (31%) of
Norwegian retail chicken meat were contaminated with extended-spectrum cephalosporin-resistant
Escherichia coli. The aim of this study was to compare selected cephalosporin-resistant E. coli from
humans and poultry to determine their genetic relatedness based on whole genome sequencing (WGS).
Methods: Escherichia coli representing three prevalent cephalosporin-resistant multi-locus sequence
types (STs) isolated from poultry (n ¼ 17) were selected from the NORM-VET strain collections. All strains
carried an IncK plasmid with a blaCMY-2 gene. Clinical E. coli isolates (n ¼ 284) with AmpC-mediated
resistance were collected at Norwegian microbiology laboratories from 2010 to 2014. PCR screening
showed that 29 of the clinical isolates harboured both IncK and blaCMY-2. All IncK/blaCMY-2-positive
isolates were analysed with WGS-based bioinformatics tools.
Results: Analysis of single nucleotide polymorphisms (SNP) in 2.5 Mbp of shared genome sequences
showed close relationship, with fewer than 15 SNP differences between ﬁve clinical isolates from urinary
tract infections (UTIs) and the ST38 isolates from poultry. Furthermore, all of the 29 clinical isolates
harboured IncK/blaCMY-2 plasmid variants highly similar to the IncK/blaCMY-2 plasmid present in the
poultry isolates.
Conclusions: Our results provide support for the hypothesis that clonal transfer of cephalosporin-
resistant E. coli from chicken meat to humans may occur, and may cause difﬁcult-to-treat infections.
Furthermore, these E. coli can be a source of AmpC-resistance plasmids for opportunistic pathogens in
the human microbiota. E.S. Berg, Clin Microbiol Infect 2017;23:407.e9e407.e15
© 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.on Control and Environmental Health, Norwegian Institute of Public Health, PO Box 4404 Nydalen, 0403 Oslo, Norway.
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Use of antimicrobials in human and veterinary medicine and in
the livestock industry drives the emergence, selection and spread of
bacterial resistance [1]. Food contaminated with antibiotic-
resistant bacteria can be a source of resistance for human patho-
gens either by direct colonization of zoonotic bacteria, or by
transfer of mobile genetic elements, e.g. plasmids, to other gut-
colonizing bacteria [2].
The World Health Organization deﬁnes extended-spectrum
cephalosporins as critically important antimicrobials for human
medicine [3]. Many studies have shown that b-lactamase-produc-
ing Escherichia coli occurs in chicken meat [3,4]. Widespread use of
cephalosporins in the broiler production pyramid and the inter-
national trade of breeding animals and hatching eggs enhance this
into a global problem [5]. However, to what extent consumption of
chicken meat contaminated by resistant bacteria affects human
health has not been established [2,6].
With the exception of coccidiostats (not classiﬁed as an anti-
biotic in Europe), Norwegian broiler production has a very low
usage of antimicrobials [7e10]. In spite of this, cephalosporin-
resistant E. coli were detected in approximately one-third of the
broilers and retail chicken ﬁllets produced in Norway in the period
from 2011 to 2014 [7e10]. A recent study showed that
cephalosporin-resistant E. coli originating from Norwegian chicken
ﬁllets had low genetic diversity, mainly limited to a fewmulti-locus
sequence types (STs), and typically carried the plasmid-mediated
AmpC (pAmpC) blaCMY-2 gene on an IncK plasmid [11]. The
poultry-associated E. coli had many of the same virulence factors as
human extraintestinal pathogenic E. coli (ExPEC), which could
facilitate human colonization and extraintestinal infections [11].Fig. 1. Pipeline for selection of isolates for whole genome-based comparison of Escherichia
MDR, multidrug resistance; ST, multi-locus sequence type.To investigate if poultry-associated strains existed among hu-
man clinical E. coli isolates with pAmpC production, we screened
isolates from microbiology laboratory and national strain collec-
tions. Isolates that were PCR positive for both IncK and blaCMY-2
were selected for whole genome sequencing (WGS). The aim of the
study was to compare human- and poultry-associated cephalo-
sporin-resistant E. coli by use of single nucleotide polymorphism
(SNP) analyses to determine the genetic relatedness of selected
AmpC-producing strains from the two reservoirs with the highest
possible resolution.
Materials and methods
Bacterial isolates
The scheme for selection and analysis of the isolates in the
present study is illustrated in Fig. 1.
Escherichia coli isolates from broilers. The poultry-associated E. coli
strains were a subset of isolates originally collected from retail
chicken meat (ﬁllets) in 2012 (n¼ 4) and 2014 (n ¼ 10) and from
chicken faecal samples in 2011 (n ¼ 3) as a part of the Norwegian
monitoring programme for antimicrobial resistance in the veteri-
nary and food production sectors (NORM/NORM-VET) [7e11]. The
monitoring program reported the following prevalence of pAmpC-
positive E. coli isolates from broilers: 43% (108/252) from intestinal
ﬂora of healthy broilers in 2011, and from chicken ﬁlet samples 32%
(66/205) and 29% (58/201) in 2012 and 2014, respectively. Brieﬂy,
the 17 isolates selected for this study belonged to phylogroup D and
carried similar conjugative IncK plasmids encoding blaCMY-2. The
strains were typed to ST38 (n ¼ 10), ST1158 (n ¼ 5) and ST115
(n ¼ 2). ST38 and ST1158were the twomost common STs among thecoli from poultry and human infections. Abbreviations: AMR, antimicrobial resistance;
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meat in 2012 and 2014 [11]. Furthermore, molecular characteriza-
tion of the chicken isolates identiﬁed virulence factor genes (e.g.
iroN, cma and iss) similar to those of ExPEC [11].
Human clinical E. coli isolates. The human clinical E. coli con-
sisted of two collections of AmpC-producing ExPEC isolates. The
ﬁrst collection (A) included 158 isolates with a blaCMY-positive ge-
notype tested as described by Brolund et al. [12]. These isolates
were from Norwegian clinical microbiology laboratories sampled
during 2010e2012 and originally submitted for veriﬁcation of the
presence of pAmpC at the Norwegian National Advisory Unit on
Detection of Antimicrobial Resistance. Submission criteria were
resistance to cefotaxime (MIC >2 mg/L) and ceftazidime (MIC
>4 mg/L) in combination with multi-drug resistance (MDR)
(deﬁned as resistance to at least two of the following groups of
antibiotics: aminoglycosides, ﬂuoroquinolones, trimethoprim-
sulfamethoxazole or nitrofurantoin). The second collection (B)
included 126 E. coli isolates displaying an AmpC phenotype iden-
tiﬁed at nine Norwegian clinical microbiology laboratories during
2013e2014. The phenotypic AmpC proﬁle was determined ac-
cording to EUCAST [13]. None of the isolates displayed classical
serine extended-spectrum b-lactamase production. The original
sample materials for the 284 human clinical E. coli isolates (of
which 84% were from UTIs) are presented in Fig. 1.
Ethical considerations
This study was approved by the Norwegian Regional Commit-
tees for Medical and Health Research Ethics (REC) (ref. 2014/419/
REK sør-øst).
Molecular characterization
PCR screening. All human clinical isolates were screened for the
presence of IncK plasmids and for the blaCMY-2 gene. Twenty-nine
E. coli isolates harboured both targets. The real-time PCR target-
ing the IncK replicon was based on previously published IncK
primers [14]. The blaCMY-2 target was ampliﬁed in triplex-PCR
format similar to a previously published real-time pAmpC PCR
[12]. Further technical details for the PCR assays are presented in
the Supplementary material (Appendix S1).
Whole genome sequencing (WGS). Human clinical (n ¼ 29) and
poultry (n ¼ 17) isolates PCR-positive for blaCMY-2 and IncK were
subjected to WGS. Paired-end genomic libraries with insert size
500 bp were made from approximately 100 ng puriﬁed DNA and
sequenced on an Illumina HiSeq 2500 system (BGI Tech Solutions
Co,. Ltd., Hong Kong). Sequencing was performed twice for two
poultry isolates (2011-01-2112 and 2012-01-1292) and one clinical
isolate (E4-14) to provide WGS reproducibility controls.
Bioinformatic analysis of WGS data
Genome assembly and in silico genotyping. The raw sequence data
were initially trimmed and cleaned for adaptors (BGI Tech Solu-
tions). The paired-end reads were further cleaned for errors and de
novo assembled into contigs (draft genomes) by the SPAdes-3.6.1
pipeline using default settings [15]. The contigs were submitted
to the Centre for Genomic Epidemiology (CGE), Technical Univer-
sity of Denmark (DTU), for bioinformatics analysis (https://cge.cbs.
dtu.dk/services/).
Identiﬁcation of SNPs and phylogenetic analysis. The paired-end
read sets, error-corrected by SPAdes, were uploaded to CSI Phy-
logeny 1.1 [16] on the DTU server by use of the default minimum
settings (https://cge.cbs.dtu.dk/services/). The assembled scaffold
of one of the poultry isolates (2012-01-1292) was used as thereference sequence by the mapping of the read sets. A selection of
completed E. coli reference genomes downloaded from National
Center for Biotechnology Information (NCBI) (http://www.ncbi.
nlm.nih.gov/genome/167) was included in the analysis to limit
the SNP calling to the phylogenetic informative genomic sequences
assumed to be representative for the E. coli core genome [17]. The
rationale was that only the evolutionarily conserved sequences
would remain as shared core genome sequences after the sequence
alignment of highly different E. coli strains [18]. A ﬁnal maximum-
likelihood tree was constructed using FIGTREE (http://tree.bio.ed.ac.
uk/software/ﬁgtree).
IncK plasmid assembly and plasmid SNP analysis. Draft se-
quences of the IncK plasmid were made by mapping of the trim-
med read sets against several IncK plasmids available from
GenBank using BIONUMERICS, version 7.5 (Applied Maths, Sint-
Martens-Latem, Belgium). The best match was obtained using
the poultry-associated strain 53C unnamed 3 IncK plasmid with
blaCMY-2 assembled by de Been et al. as reference (Accession no.
NZ_JXMX01000007.1, (https://www.ncbi.nlm.nih.gov/nuccore/
NZ_JXMX01000007.1?report¼GenBank) [19]. Finally, paired-end
read sets from each isolate were uploaded to CSI phylogeny for
SNP-based plasmid similarity analysis using the 53C IncK plasmid
as reference.
BEAST simulation. To estimate a timeline for the diversiﬁcation
of the most closely related isolates of poultry and human origin,
Bayesian Evolutionary Analysis Sampling Trees, BEAST version 1.7
software was used with input from CSI Phylogeny analysis of the
15 most closely related isolates [20]. A basic assumption for the
time estimation was that any SNPs located in recombination sites
of the E. coli genomes had been removed in the CSI Phylogeny
analysis, i.e. by pruning the SNPs. Among several models of evo-
lution, the chosen model with the best ﬁt assumed an uncorre-
lated relaxed molecular clock, expansion growth in population
size and a lognormal distribution of the mutation rate. All the
BEAST Monte Carlo Markov Chain simulations were run for 150
million steps, and samples were saved every 10 000 steps. A single
maximum clade credibility tree was produced using the TREEAN-
NOTATOR tool in the BEAST pipeline, where 10% of the Monte Carlo
Markov Chain steps were removed as burn-in. A ﬁnal tree was
constructed using FIGTREE.
Results
In total, 29 of the 284 clinical E. coli isolates were PCR positive
for both blaCMY-2 and IncK. In collection A, consisting of 158
genotypic blaCMY-2-positive MDR clinical isolates, 16 carried IncK
plasmids (14 isolates from UTIs, one isolate from bloodstream
infection, and one isolate from an unknown body site). In collection
B with 126 phenotypic AmpC-positive clinical isolates, 53 isolates
were blaCMY-2-positive and 13 of these were also IncK positive (11
isolates fromUTIs, one isolate from a perianal abscess and one from
an unknown body site) (see Supplementary material, Table S1,
Appendix S1).
WGS-based in silico genotyping of the 29 IncK/blaCMY-2-positive
isolates revealed a diversity of other plasmid replicons (e.g. IncFIB,
IncFII and IncI1), acquired antibiotic resistance genes (e.g. blaTEM-
1B, sul1/2 and strA/B), STs (e.g. ST38, ST69 and ST131), serotypes
(e.g. O7:H18, O17/O77:H18 and O25:H4) and virulence factors (e.g.
iroN, cma, iss, eilA and iha) (see Supplementary material, Appendix
S1, Table S2 and Fig. S2). A subset of the human isolates (n ¼ 7), all
from UTIs, showed genotypic features similar to the most preva-
lent poultry-associated E. coli strains (ST38, phylogroup D, sero-
type O7:H18, carriage of IncK, IncFIB-, IncFII- and p0111 plasmids,
and iroN, cma, iss and eilA virulence factor genes) [11] (see
Supplementary material, Appendix S1, Table S2 and Fig. S2).
E.S. Berg et al. / Clinical Microbiology and Infection 23 (2017) 407.e9e407.e15407.e12The CSI Phylogeny pipeline identiﬁed 56 610 valid SNP positions
in the shared core genome of 2.51 Mbp of the 29 clinical isolates,
the 17 poultry strains and the 23 NCBI reference strains. The
phylogenetic analysis revealed that the majority of the 29 clinical
isolates were genetically diverse and not closely related to the
poultry isolates (Fig. 2). However, from the subset of the seven ST38
UTI isolates, ﬁve clustered together with the ten ST38 poultryFig. 2. Genome single nucleotide polymorphism (SNP) differences in human clinical Esch
collected from Norwegian retail chicken ﬁllets. Multiple sequence alignment resulted in 56.
labels show the span in SNP differences within the group of isolates.
Fig. 3. Dendrogram after whole genome comparison with single nucleotide polymorphism
infections, poultry samples and a selection of GenBank E. coli reference genomes retrieved fr
multilocus sequence types (STs) of the included poultry isolates and of isolates of clinical
supplementary material. The length of the scale bar represents the average number of subisolates (Fig. 3). The number of SNP differences between these UTI
and poultry isolates was only 1e13 (Fig. 2 and see Supplementary
material, Appendix S1 and Fig. S2). The remaining ST38 clinical
isolates, E2-21 and E4-13 had 34 and 529 SNP differences, respec-
tively, compared with the ST38 reference poultry isolate (Fig. 2 and
see Supplementary material, Appendix S1 and Fig. S2). In contrast,
pairwise comparison of any of the ST38 poultry isolates to the non-erichia coli isolates compared with one AmpC-producing poultry E. coli (ST38) strain
610 valid SNPs in the core genome of 2.51 Mbp positions shared by all strains. The data
(SNP) calling and phylogenetic analysis of Escherichia coli isolates from human clinical
om GenBank. The colours of the boxes reﬂect the origin of the isolates as indicated. The
relevance are indicated on the ﬁgure. STs of all investigated isolates can be found in
stitutions per site at the variable sites.
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genomes, resulted in 4000e10 600 SNP differences. The poultry
strains clustered in three genetically diverse groups according to
their STs and showed few SNP differences within each group (ST38
group up to eight SNP differences, ST1158 group up to ﬁve SNP
differences, and ST115 group one SNP difference) (Figs. 2 and 3). For
the three isolates that were sequenced twice as WGS reproduc-
ibility controls, no SNP differences were observed between each
pair (see Supplementary material, Appendix S1 and Fig. S2).
Mapping of the paired-end read sets to the 53C unnamed 3 IncK
plasmid sequence re-constructed by de Been et al. [19] showed that
the 29 clinical isolates and the poultry strains had IncK plasmid
variants highly similar to the 53C reference plasmid (85.9 kb) albeit
with a size range of 80e85 kb. The closely related human clinical
and chicken isolates as well as the rest of the clinical and poultry
isolates shared an IncK plasmid backbone with a 79-kb core
sequence. The CSI phylogeny analysis clustered the IncK variants
from most of the isolates into one large group whereas the ﬁve
ST1158 poultry isolates formed a separate group (see
Supplementary material, Appendix S1 and Fig. S3).
The genome sequences of the closely related clinical ST38
UTI isolates (n ¼ 5) and the poultry strains (n ¼ 10) were
subjected to a new CSI Phylogeny analysis to produce data input to
the BEAST simulation. The SNP alignments were used as input to
the BEAST analyses that estimated the point in time for the diver-
siﬁcation of the ancestor of the 15 closely related isolates to year
2005 with a mutation rate of 0.0098 mutations/genome/year
(Fig. 4). The ﬁnal tree illustrates that the ﬁve clinical UTI E. coli
isolates belonged to three different clusters (Fig. 4). Apparently, the
genetic diversity within this group of UTI isolates was within the
same order of magnitude as the genetic diversity between the UTI
and poultry isolates.2011-01-7660
2012-01-
2012-01-
E2-35 (
2011-01-2112_ctr
2011-01-5432
2012-01-1
2012
Time for development of S
2011-01-2112
2012-01-1
E2-5
Fig. 4. Bayesian Evolutionary Analysis Sampling Trees (BEAST) analysis of the closely related
urinary tract isolates.Discussion
The aim of this study was to use WGS-based SNP analysis to
achieve the best discriminatory power by the determination of the
genetic relatedness of a selected group of AmpC-producing human
clinical ExPEC isolates compared with cephalosporin-resistant
E. coli found in retail chicken ﬁllets. To focus the investigation on
isolates that might have received their AmpC-resistance from
poultry-associated E. coli, the presence of IncK and blaCMY-2 was
used as a selection criterion for the human clinical isolates [11]. The
PCR screening showed that 29 of the 284 AmpC-producing human
clinical isolates were IncK/ blaCMY-2-positive. This indicates that the
majority (n ¼ 182) of our blaCMY-2-positive clinical ExPECs have
acquired the pAmpC from other sources than the cephalosporin-
resistant E. coli found in chicken ﬁllets and were therefore unre-
lated to the chicken meat E. coli. Sequence analysis after WGS
conﬁrmed that all of the 29 clinical isolates selected in the
screening carried a plasmid backbone with high similarity to the
IncK/blaCMY-2 plasmid in the poultry-associated E. coli.
The WGS-based in silico low-resolution E. coli genotyping of the
29 clinical strains showed that most of these ExPEC isolates were
distantly related to the poultry E. coli. However, seven of them, all
from UTIs, belonged to ST38. The dominating cephalosporin-
resistant E. coli isolated from the Norwegian retail chicken ﬁllets
also belonged to this ST [11]. Several European studies have shown
that ST38 is associated with human UTIs, and in addition, may
occur as a contaminant of chicken meat [21e25]. The phylogenetic
SNP-based analysis provided higher resolution than multilocus
sequence typing and showed that only ﬁve of the seven clinical
ST38 ExPEC isolates were nearly identical to the dominating ST38
E. coli isolates collected from poultry (n ¼ 10). The high-resolution
comparisons of informative SNPs within the multiple sequenceE3-39 (2013)
1553
1849
2012)
l
292_ctrl
E4-35 (2014)
E4-46 (2014)
2014-01-1044
2014-01-1040
2014-01-1675
-01-6001
NPs
292
6 (2012)
E. coli
from poultry
E. coli from 
urinary tract infections
human and chicken Escherichia coli isolates. Yellow boxes; poultry isolates, pink boxes;
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ence strains, the poultry and human isolates revealed very few SNP
differences (< 15) between these 15 ST38 isolates. Hereby, the SNP-
based phylogenetic result strongly suggests a link between these
isolates. Extrapolation and comparison of our ﬁndings to similar
studies using E. coli core genomes derived from proteome analyses
indicate that our ten poultry and ﬁve UTI isolates were as closely
related as would be expected for clones in a foodborne E. coli
outbreak [6,19]. With the assumption that the isolates were clonal,
the BEAST analyses determined the timewhen these 15 human and
poultry E. coli isolates diverged from a common ancestor to year
2005. The BEAST output showed that the ﬁve clinical E. coli isolates
were positioned among the poultry isolates in three different
clusters. Furthermore, the diversity within these human ExPEC
isolates was in the same low order of magnitude as the diversity
between the human and poultry E. coli isolates.
A limitation of our study is the lack of epidemiological data of
patient exposure to chicken meat to strengthen the hypothesis of
resistance transmission from poultry to human. Alternatively, data
of exposure to other potential sources of antimicrobial resistance
could weaken the hypothesis. In addition, the BEAST analysis that
was based on only 15 isolates collected over a short time period
could not show the evolution of the strains in the two compart-
ments over time. Another limitation of our study is the narrow
focus on comparison of SNPs in E. coli from the two reservoirs
without a view to identify the genes harbouring the SNPs to see a
potential biological signiﬁcance or to study the evolution of ST38
ExPEC. Consumption of chicken meat contaminated with
cephalosporin-resistant E. coli can be a driver for increasing
occurrence of pAmpC-positive pathogens causing human in-
fections. Previous ﬁndings have demonstrated the same plasmid-
mediated resistance genes (e.g. blaCTX-M, blaSHV, blaTEM and
blaCMY-2), the same mobile genetic element, and highly similar
genotypes of E. coli in humans and retail chicken meat. These
studies have indicated a common link between these reservoirs
[21,25e30]. The WGS-based genome comparisons enabled us to
investigate if transmission of resistance may occur by whole bac-
terium clonal transfer between poultry and humans. Furthermore,
the high-resolution sequence comparison also enabled us to
investigate if the resistance transmissions may have occurred by
horizontal dissemination of plasmids between bacteria. The results
of this study provide support for the hypothesis that clonal trans-
mission of AmpC-producing E. coli between poultry and humans
may occur. Our results based on the SNP comparisons and the
BEAST analysis showed that certain ST38 strains from the two
reservoirs are very closely related and that they may have a com-
mon ancestor. Since the strains are highly similar, we cannot ﬁrmly
decide in which direction the transmission between the two res-
ervoirs occurred. However, contaminated poultry meat is a recog-
nized source for infections with other zoonotic bacteria such as
Campylobacter. This strengthens the hypothesis that a recent clonal
transfer of resistant E. coli might have occurred from a poultry
reservoir to human hosts. With the low number of SNP differences
(<6 SNPs per Mbp core genome) and close genetic relatedness
between the ST38 strains from human and poultry, our results
differ from the data from the Netherlands [19]. De Been et al.
identiﬁed 1263 SNP differences per Mbp core genome between
their most closely related human and poultry isolates collected in
2006e2011 [19]. The dissimilar results of the two studies may be
explained by different sampling strategies and selection of isolates.
We found similar IncK plasmid variants with blaCMY-2 both in the
clonally related human clinical isolates (n ¼ 5) and the poultry
strains (n ¼ 10), and in the rest of the clinical isolates (n ¼ 24) and
the poultry strains (n ¼ 7). This suggests that horizontal transfer of
resistance plasmids seems to occur with higher frequency thanclonal transmission of resistant bacteria. Our results are in line with
the results from other studies, and supports that plasmids are
signiﬁcant vectors for antimicrobial resistance dissemination
[19,31]. Building an IncK/blaCMY-2 plasmid scaffold by positioning
the WGS read sets against the 53C unnamed 3 IncK plasmid
(86.0 kb), resulted in a common plasmid backbone sequence of
79 kb for all of our 29 ExPEC isolates. This plasmid backbone might
be a part of many of the variants of blaCMY-2-containing IncK plas-
mids detected in the E. coli population of broilers in parts of Europe
during the last few years [11,19,21e25,32]. Notably, in addition to
blaCMY-2, the poultry-associated IncK plasmid backbone has two
plasmid addiction systems that ensure stable maintenance of the
plasmid within each of the daughter cells after cell division [11,33].
Plasmid addiction systems increase the potential for persistence
regardless of any antimicrobial selection pressure. In addition, they
may increase the potential for resistance plasmid transmission to
opportunistic pathogens or to other bacteria in the human and
poultry gut microbiota or in environmental reservoirs [33].
Even if only a small fraction of pAmpC-producing ExPEC in
human infections is attributable to contaminated food, this is a
signiﬁcant public health concern [6]. Our approach based on tar-
geted selection of resistant isolates for WGS-based high-resolution
comparisons supports that transmission of antimicrobial resistance
may occur both by clonal transfer of E. coli from poultry to humans
and more frequently by the transfer of plasmids to pathogenic
E. coli adapted to humans.
In conclusion, 20% of the 29 selected IncK/blaCMY-2-positive
ExPEC isolates showed very close relatedness to cephalosporin-
resistant E. coli found in retail chicken ﬁllets. The remaining 80%
of the clinical isolates exhibited a pAmpC vector highly similar to
the IncK plasmid carried by the cephalosporin-resistant E. coli
associated with poultry. This study supports the hypothesis that
transfer of antimicrobial resistance may occur between poultry and
humans both by clonal transmission and, more frequently, by
plasmid dissemination.
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